Who owns Beam Therapeutics Inc. (BEAM)? Elite investor 13F holders
7 tracked elite investors reported holding Beam Therapeutics Inc as of 2026-06-30, including Renaissance Technologies LLC, Alphabet, Duquesne Family Office, D.E. Shaw, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
7 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. Its programs in hematology and genetic disease portfolio include Ristoglogene autogetemcel, a patient-specific, autologous hematopoietic stem cell (HSC) therapy for the treatment of sickle cell disease; BEAM-302, a…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | BEAM THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 15272400.00 USD | 445000.000000 | Shares | reduce | Original filing |
| Alphabet | BEAM THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-07 00:00:00 | 11037449.00 USD | 321604.000000 | Shares | hold | Original filing |
| Duquesne Family Office | BEAM THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 5272000.00 USD | 153600.000000 | Shares | buy | Original filing |
| D.E. Shaw | BEAM THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 4481402.00 USD | 130577.000000 | Shares | buy | Original filing |
| Tudor Investment | BEAM THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1684837.00 USD | 49092.000000 | Shares | add | Original filing |
| Gotham Asset Management | BEAM THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 367910.00 USD | 10720.000000 | Shares | buy | Original filing |
| Ancora Advisors / Ancora Holdings | BEAM THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1716.00 USD | 50.000000 | Shares | hold | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.